Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy)
dc.contributor.author | Cumurcu, Tongabay | |
dc.contributor.author | Cumurcu, Birgül Elbozan | |
dc.contributor.author | Zayman, Esra Porgalı | |
dc.contributor.author | Çavdar, Müfide | |
dc.contributor.author | Nurlu, Kayhan | |
dc.contributor.author | Doğanay, Selim | |
dc.date.accessioned | 2020-05-27T18:15:01Z | |
dc.date.available | 2020-05-27T18:15:01Z | |
dc.date.issued | 2017 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | Öz:A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe):Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe): | en_US |
dc.description.abstract | Öz: A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe): Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe): | en_US |
dc.identifier.citation | Tongabay C., Birgül ELBOZAN C., Esra PORGALI Z., Müfide Ç., Kayhan N., Selim D. (2017). Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy), Retina-Vitreus, İnönü Üniversitesi, Malatya. | en_US |
dc.identifier.endpage | 271 | en_US |
dc.identifier.issn | 1300-1256 | |
dc.identifier.issn | 2717-7149 | |
dc.identifier.startpage | 269 | en_US |
dc.identifier.trdizinid | 296698 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/15598 | |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/296698 | |
dc.identifier.volume | 26 | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.language.iso | tr | en_US |
dc.publisher | Retina-Vitreus | en_US |
dc.relation.ispartof | Retina-Vitreus | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Göz Hastalıkları | en_US |
dc.title | Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy) | en_US |
dc.title.alternative | Muhtemel Sertraline Bağlı Santral Seroz Retinopati | en_US |
dc.type | Article | en_US |